Impact of prenatal corticosteroid therapy ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant women.
Auteur(s) :
Wang, Florence [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Mandelbrot, Laurent [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Affo, Louis [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Galacteros, Frédéric [Auteur]
CHU Henri Mondor [Créteil]
Bounan, Stéphane [Auteur]
Centre Hospitalier de Saint-Denis [Ile-de-France]
Fernandez, Hervé [Auteur]
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
Fichez, Axel [Auteur]
Hôpital de la Croix-Rousse [CHU - HCL]
Cannas, Giovanna [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Driessen, Marine [Auteur]
Hôpital Necker - Enfants Malades [AP-HP]
Debarge, Veronique [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Loko, Gylna [Auteur]
Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique] [CHU de Martinique]
Gnofam, Mayi [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Makowski, Caroline [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Graesslin, Olivier [Auteur]
Hôpital Maison Blanche
Haddad, Bassam [Auteur]
Centre Hospitalier Intercommunal de Créteil [CHIC]
Sibiude, Jeanne [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Hôpital Louis Mourier - AP-HP [Colombes]
Mandelbrot, Laurent [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Affo, Louis [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Galacteros, Frédéric [Auteur]
CHU Henri Mondor [Créteil]
Bounan, Stéphane [Auteur]
Centre Hospitalier de Saint-Denis [Ile-de-France]
Fernandez, Hervé [Auteur]
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
Fichez, Axel [Auteur]
Hôpital de la Croix-Rousse [CHU - HCL]
Cannas, Giovanna [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Driessen, Marine [Auteur]
Hôpital Necker - Enfants Malades [AP-HP]
Debarge, Veronique [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Loko, Gylna [Auteur]
Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique] [CHU de Martinique]
Gnofam, Mayi [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Makowski, Caroline [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Graesslin, Olivier [Auteur]
Hôpital Maison Blanche
Haddad, Bassam [Auteur]
Centre Hospitalier Intercommunal de Créteil [CHIC]
Sibiude, Jeanne [Auteur]
Hôpital Louis Mourier - AP-HP [Colombes]
Titre de la revue :
International Journal of Gynecology and Obstetrics
Nom court de la revue :
Int J Gynaecol Obstet
Date de publication :
2023-05-13
ISSN :
1879-3479
Mot(s)-clé(s) en anglais :
vaso-occlusive crisis
sickle cell disease
preterm birth
prenatal corticosteroids
pregnancy
sickle cell disease
preterm birth
prenatal corticosteroids
pregnancy
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Objective
To evaluate safety of prenatal corticosteroids in pregnancies of women with sickle cell disease.
Methods
A multicenter observational study of patients with sickle cell disease, comparing vaso-occlusive ...
Lire la suite >Objective To evaluate safety of prenatal corticosteroids in pregnancies of women with sickle cell disease. Methods A multicenter observational study of patients with sickle cell disease, comparing vaso-occlusive crises (VOC) requiring hospital care between pregnancies with versus without prenatal corticosteroids. Results In 40 pregnancies exposed to prenatal corticosteroids, compared with 370 unexposed pregnancies, VOC were not more frequent (62.5% vs 57.9%, P = 0.578) but they were more severe, with more intensive care hospitalizations (25.0% vs 12.9%, P = 0.039), emergency transfusions (44.7% vs 22.7%, P = 0.006), and acute chest syndromes (22.5% vs 8.9%, P = 0.010). These differences persisted after adjustment for severity and type of sickle cell syndrome (for intensive care admission adjusted odds ratio [aOR] 2.73, 95% confidence interval [CI] 1.10–6.79, P = 0.031 and for acute chest syndrome aOR 4.15, 95% CI 1.57–14.4, P = 0.008). VOC occurred on average 1.2 days following steroid administration. When comparing 36 patients receiving corticosteroids for fetal maturation with 58 patients who were hospitalized for obstetrical complications before 34 weeks of pregnancy but that did not receive corticosteroids, VOC incidence was not significantly higher (41.7% vs 31.5%, P = 0.323). Conclusion The present study was the first to study the impact of prenatal corticosteroids on sickle cell disease. They were associated with more severe VOC, suggesting that steroids should be avoided in these women.Lire moins >
Lire la suite >Objective To evaluate safety of prenatal corticosteroids in pregnancies of women with sickle cell disease. Methods A multicenter observational study of patients with sickle cell disease, comparing vaso-occlusive crises (VOC) requiring hospital care between pregnancies with versus without prenatal corticosteroids. Results In 40 pregnancies exposed to prenatal corticosteroids, compared with 370 unexposed pregnancies, VOC were not more frequent (62.5% vs 57.9%, P = 0.578) but they were more severe, with more intensive care hospitalizations (25.0% vs 12.9%, P = 0.039), emergency transfusions (44.7% vs 22.7%, P = 0.006), and acute chest syndromes (22.5% vs 8.9%, P = 0.010). These differences persisted after adjustment for severity and type of sickle cell syndrome (for intensive care admission adjusted odds ratio [aOR] 2.73, 95% confidence interval [CI] 1.10–6.79, P = 0.031 and for acute chest syndrome aOR 4.15, 95% CI 1.57–14.4, P = 0.008). VOC occurred on average 1.2 days following steroid administration. When comparing 36 patients receiving corticosteroids for fetal maturation with 58 patients who were hospitalized for obstetrical complications before 34 weeks of pregnancy but that did not receive corticosteroids, VOC incidence was not significantly higher (41.7% vs 31.5%, P = 0.323). Conclusion The present study was the first to study the impact of prenatal corticosteroids on sickle cell disease. They were associated with more severe VOC, suggesting that steroids should be avoided in these women.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
CHU Lille
Date de dépôt :
2023-11-15T02:02:41Z
2024-04-04T09:35:12Z
2024-04-04T09:35:12Z
Fichiers
- Intl J Gynecology Obste - 2023 - Wang - Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant.pdf
- Non spécifié
- Accès libre
- Accéder au document
- Intl J Gynecology Obste - 2023 - Wang - Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant.pdf
- Non spécifié
- Accès libre
- Accéder au document